X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5) 5
aged (4) 4
cardiovascular (4) 4
female (4) 4
humans (4) 4
male (4) 4
middle aged (4) 4
treatment outcome (4) 4
cardiac & cardiovascular systems (3) 3
japan (3) 3
adult (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer (2) 2
chemotherapy (2) 2
drug administration schedule (2) 2
drug combinations (2) 2
oncology (2) 2
percutaneous coronary intervention (2) 2
proportional hazards models (2) 2
research (2) 2
risk factors (2) 2
stomach neoplasms - drug therapy (2) 2
time factors (2) 2
1st-line therapy (1) 1
5-fluorouracil (1) 1
absorbable implants (1) 1
acute coronary syndrome (1) 1
acute coronary syndrome - complications (1) 1
acute coronary syndrome - diagnosis (1) 1
acute coronary syndrome - mortality (1) 1
acute coronary syndrome - surgery (1) 1
acute coronary syndrome - therapy (1) 1
acute myocardial-infarction (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
administration, oral (1) 1
advanced esophagogastric cancer (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antitumor-activity (1) 1
article (1) 1
aspirin - administration & dosage (1) 1
aspirin - adverse effects (1) 1
atherectomy, coronary - adverse effects (1) 1
atherectomy, coronary - instrumentation (1) 1
atherectomy, coronary - methods (1) 1
balloon angioplasty (1) 1
biodegradable polymer (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - analogs & derivatives (1) 1
carcinoma (1) 1
chronic total occlusion (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
clinical outcomes (1) 1
clinical study (1) 1
clinical trials (1) 1
clinical-trials (1) 1
clopidogrel (1) 1
combination chemotherapy (1) 1
complications (1) 1
computed tomography (1) 1
contemporary (1) 1
continuous-infusion 5-fluorouracil (1) 1
cooperative group (1) 1
coronary angiography (1) 1
coronary arteries (1) 1
coronary artery disease (1) 1
coronary artery disease - complications (1) 1
coronary artery disease - diagnosis (1) 1
coronary artery disease - mortality (1) 1
coronary artery disease - therapy (1) 1
coronary dissection (1) 1
coronary heart disease (1) 1
coronary intervention (1) 1
debulking (1) 1
disease-free survival (1) 1
dissection (1) 1
doxorubicin (1) 1
drug therapy, combination (1) 1
drug-eluting stent (1) 1
drug-eluting stents (1) 1
dual antiplatelet therapy (1) 1
duration (1) 1
european-organization (1) 1
fluorouracil (1) 1
fluorouracil - adverse effects (1) 1
fluorouracil - therapeutic use (1) 1
folinic acid (1) 1
gastric cancer (1) 1
gastric cancer, unresectable and/or metastatic (1) 1
gastrointestinal diseases (1) 1
heart attack (1) 1
hematology, oncology and palliative medicine (1) 1
hemorrhage - chemically induced (1) 1
high-dose methotrexate (1) 1
i/ii (1) 1
iii trial (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 12, pp. 1189 - 1198
Abstract Objectives The NIPPON (Nobori Dual Antiplatelet Therapy as Appropriate Duration) study was a multicenter randomized investigation of the... 
Cardiovascular | dual antiplatelet therapy | net adverse clinical and cerebrovascular event(s) | biodegradable polymer | stent thrombosis | drug-eluting stent(s) | net adverse clinical and erebrovascular event(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | RISK | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | PREDICTORS | CLINICAL-TRIALS | COMPLICATIONS | DURATION | Myocardial Infarction - mortality | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Prosthesis Design | Aspirin - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Acute Coronary Syndrome - complications | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Stroke - mortality | Drug Therapy, Combination | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Japan | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Ticlopidine - analogs & derivatives | Absorbable Implants | Stroke - etiology | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Acute Coronary Syndrome - diagnosis | Intention to Treat Analysis | Acute Coronary Syndrome - therapy | Clopidogrel | Polymers - chemistry | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects
Journal Article
Journal of Cardiology Cases, ISSN 1878-5409, 2016, Volume 15, Issue 3, pp. 84 - 87
Abstract Spontaneous coronary artery dissection (SCAD) is a rare and often fatal cause of ischemic heart disease that occurs predominantly in young or... 
Cardiovascular | Myocardial infarction | Coronary dissection | Intravascular ultrasound
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 11, pp. 1063 - 1069
Summary Background The best chemotherapy regimen for metastatic gastric cancer is uncertain, but promising findings have been reported with irinotecan plus... 
Hematology, Oncology and Palliative Medicine | SUPPORTIVE CARE | 5-FLUOROURACIL | ONCOLOGY | HIGH-DOSE METHOTREXATE | DOXORUBICIN | ADVANCED ESOPHAGOGASTRIC CANCER | COOPERATIVE GROUP | EUROPEAN-ORGANIZATION | 1ST-LINE THERAPY | III TRIAL | CHEMOTHERAPY | Japan - epidemiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - secondary | Cisplatin - administration & dosage | Young Adult | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Time Factors | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Drug Administration Schedule | Risk Assessment | Administration, Oral | Tegafur - adverse effects | Tegafur - therapeutic use | Proportional Hazards Models | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Oxonic Acid - adverse effects | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Infusions, Intravenous | Stomach Neoplasms - mortality | Drug Combinations | Adenocarcinoma - mortality | Chemotherapy | Oncology, Experimental | Information services | Research | Metastasis | Stomach cancer | Information services industry | Cancer | Fluorouracil | Index Medicus
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.